Endologix to Present at the 27th Annual ROTH Conference
March 03, 2015 09:00 ET
|
Endologix
IRVINE, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
Endologix Reports 10% and 12% Revenue Growth for the Fourth Quarter and Full Year 2014
February 25, 2015 16:05 ET
|
Endologix
Includes 12% Constant Currency Revenue Growth for the Fourth Quarter and Full Year 2014
Provides 2015 Financial Guidance
IRVINE, Calif., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc....
Endologix to Report Fourth Quarter and Full Year 2014 Financial Results on February 25, 2015
January 26, 2015 09:00 ET
|
Endologix
IRVINE, Calif., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the...
Endologix to Present at the 33rd Annual J.P. Morgan Healthcare Conference
January 05, 2015 09:00 ET
|
Endologix
IRVINE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
Endologix to Participate in Two Investor Conferences in December
November 25, 2014 09:00 ET
|
Endologix
IRVINE, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Company management is...
Nellix Clinical Data From the EVAS FORWARD Global Registry Presented at 2014 VEITH Symposium
November 20, 2014 08:15 ET
|
Endologix
IRVINE, Calif., Nov. 20, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of initial...
Endologix Completes Patient Enrollment in the Nellix(R) EVAS FORWARD-IDE Clinical Trial
November 18, 2014 07:00 ET
|
Endologix
IRVINE, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient...
Endologix to Participate in Three Investor Conferences in November
November 06, 2014 16:30 ET
|
Endologix
IRVINE, Calif., Nov. 6, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Company management is...
Endologix to Host Investor Meeting on Thursday, November 20, 2014
November 03, 2014 09:00 ET
|
Endologix
IRVINE, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details for its 2014 investor...
Endologix Reports 12% Global Revenue Growth for the Third Quarter 2014
October 30, 2014 16:05 ET
|
Endologix
IRVINE, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...